z-logo
open-access-imgOpen Access
Mutations in C5ORF42 Cause Joubert Syndrome in the French Canadian Population
Author(s) -
Myriam Srour,
Jeremy Schwartzentruber,
Fadi F. Hamdan,
Luis H. Ospina,
Lysanne Patry,
Damian Labuda,
Christine Massicotte,
Sylvia Dobrzeniecka,
JoséMario CapoChichi,
Simon PapillonCavanagh,
Mark E. Samuels,
Kym M. Boycott,
Michael Shevell,
Rachel Laframboise,
Valérie Désilets,
Bruno Maranda,
Guy A. Rouleau,
Jacek Majewski,
Jacques L. Michaud
Publication year - 2012
Publication title -
the american journal of human genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.661
H-Index - 302
eISSN - 1537-6605
pISSN - 0002-9297
DOI - 10.1016/j.ajhg.2012.02.011
Subject(s) - genetics , joubert syndrome , compound heterozygosity , missense mutation , exome sequencing , population , hypotonia , mutation , biology , founder effect , allele , medicine , haplotype , gene , environmental health
Joubert syndrome (JBTS) is an autosomal-recessive disorder characterized by a distinctive mid-hindbrain malformation, developmental delay with hypotonia, ocular-motor apraxia, and breathing abnormalities. Although JBTS was first described more than 40 years ago in French Canadian siblings, the causal mutations have not yet been identified in this family nor in most French Canadian individuals subsequently described. We ascertained a cluster of 16 JBTS-affected individuals from 11 families living in the Lower St. Lawrence region. SNP genotyping excluded the presence of a common homozygous mutation that would explain the clustering of these individuals. Exome sequencing performed on 15 subjects showed that nine affected individuals from seven families (including the original JBTS family) carried rare compound-heterozygous mutations in C5ORF42. Two missense variants (c.4006C>T [p.Arg1336Trp] and c.4690G>A [p.Ala1564Thr]) and a splicing mutation (c.7400+1G>A), which causes exon skipping, were found in multiple subjects that were not known to be related, whereas three other truncating mutations (c.6407del [p.Pro2136Hisfs*31], c.4804C>T [p.Arg1602*], and c.7477C>T [p.Arg2493*]) were identified in single individuals. None of the unaffected first-degree relatives were compound heterozygous for these mutations. Moreover, none of the six putative mutations were detected among 477 French Canadian controls. Our data suggest that mutations in C5ORF42 explain a large portion of French Canadian individuals with JBTS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom